Comparison of liver function with two new/mixed intravenous lipid emulsions in children with intestinal failure
Authors:
- 25 June 2014
- journal article
- research article
- Published by Springer Nature in European Journal of Clinical Nutrition
- Vol. 68 (10) , 1161-1167
Abstract
The high incidence of liver disease associated with intravenous soybean lipid has led to development and use of alternative intravenous lipid emulsions (ILEs). The aim of this study was to compare two new/mixed ILEs: a medium-chain triglyceride (MCT) combined with soybean (i.e., Lipofundin) and a combination of both these lipids with additional olive and fish oils (SMOF). Neonates/premature infants newly starting parenteral nutrition (PN) treatment and children with abnormal liver function tests, alanine transferase (ALT), alkaline phosphatase (ALP), γ-glutamyl transferase (γ-GT) 1.5x upper limit of normal and/or total bilirubin >50 μmol/l for >2 weeks on treatment with PN containing pure soybean ILE (Intralipid 20%; Fresenius Kabi), were started on/changed to either SMOF or Lipofundin. RESULTS of biochemistry and clinical outcome were compared on commencing and discontinuing treatment according to the new ILE used. One hundred and twenty-seven children aged 0-16 (median 0.6) years were included. Fifity-six were given Lipofundin and 71 SMOF. Fifty-three of 127 started PN for the first time and 74 had had previous treatment with Intralipid. During treatment, ALT and ALP levels fell significantly (P<0.008 on SMOF; P<0.05 on Lipofundin), with additional significant reduction in γ-GT with SMOF. Hyperbilirubinaemia incidence decreased from 34% on starting to 24% on discontinuing treatment (P⩽0.05). Infection rate/1000 catheter days, full blood count, serum triglyceride and cholesterol levels were similar with both ILEs. Addition of MCT to soybean ILE was associated with improved liver function. There was an even greater improvement when olive and fish oils were also added with higher incidence of resolution of abnormal liver function tests and reduced inflammation.Keywords
This publication has 40 references indexed in Scilit:
- Intestinal failure-associated liver disease in hospitalised childrenArchives of Disease in Childhood, 2012
- The use of Omegaven in treating parenteral nutrition-associated liver diseaseJournal of Perinatology, 2011
- Fish oil containing intravenous lipid emulsions in parenteral nutrition-associated cholestatic liver diseaseCurrent Opinion in Clinical Nutrition and Metabolic Care, 2010
- Parenteral Fish Oil as Monotherapy Prevents Essential Fatty Acid Deficiency in Parenteral Nutrition–dependent PatientsJournal of Pediatric Gastroenterology and Nutrition, 2010
- Parenteral Fish Oil Improves Outcomes in Patients With Parenteral Nutrition-Associated Liver InjuryAnnals of Surgery, 2009
- The British Intestinal Failure Survey (BIFS): A referral registry to record and determine the outcome of childhood intestinal failureProceedings of the Nutrition Society, 2009
- Some new insights in intestinal failure-associated liver diseaseCurrent Opinion in Organ Transplantation, 2009
- Safety and Efficacy of a New Parenteral Lipid Emulsion (SMOFlipid) in Surgical Patients: A Randomized, Double-Blind, Multicenter StudyAnnals of Nutrition and Metabolism, 2006
- Parenteral nutrition—Related cholestasis in postsurgical neonates: Multivariate analysis of rick factorsJournal of Pediatric Surgery, 1996
- Glucose versus glucose-fat mixture in the course of total parenteral nutrition: effects on substrate utilisation and energy metabolism in malnourished childrenClinical Nutrition, 1991